Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
357 COTI-2 is a type of thiosemicarbazone and is the only compound that has been tested in clinical trials for drugs targeting the p53 (R175H) mutant
This process: Reduces the toxic burden on your organs Boosts energy levels Enhances overall health and vitality 2
A medical evaluation is still necessary before choosing any medication or procedure
And its only open to people who meet certain health criteria
Out-of-pocket costs are the strongest predictor of abandonment: High OOP costs drive non-adherence, especially in obesity, where coverage is limited and stigma persists
US$ 20.63
US$ 22.28
US$ 23.47
US$ 25.69
US$ 25.79
